Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Feinmesser, E. Okon, Ariel Schwartz, E. Kaganovsky, B. Hardy, Elena Aminov, B. Nageris, J. Sulkes, R. Feinmesser (2004)
Histologic and immunohistochemical characterization of tumor and inflammatory infiltrates in oral squamous cell carcinomas treated with local multikine immunotherapy: the macrophage at the front lineEuropean Archives of Oto-Rhino-Laryngology and Head & Neck, 261
L. Fong, D. Brockstedt, C. Benike, Jami Breen, G. Strang, C. Ruegg, E. Engleman (2001)
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy1The Journal of Immunology, 167
S. Shintani, M. Mihara, Y. Nakahara, N. Terakado, Y. Yoshihama, A. Kiyota, Y. Ueyama, T. Matsumura (2000)
Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas.Cancer letters, 154 1
G. Cortesina, A. Stefani, M. Giovarelli, Maria Barioglio, G. Cavallo, C. Jemma, G. Forni (1988)
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphaticallyCancer, 62
Y. Naito, Kazuya Saito, K. Shiiba, A. Ohuchi, K. Saigenji, H. Nagura, H. Ohtani (1998)
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.Cancer research, 58 16
G. Adema, I. Vries, C. Punt, C. Figdor (2005)
Migration of dendritic cell based cancer vaccines: in vivo veritas?Current opinion in immunology, 17 2
A. Santin (2000)
Lymph node metastasesCancer, 88
I. Mazo, M. Honczarenko, Harry Leung, L. Cavanagh, R. Bonasio, W. Weninger, K. Engelke, Lijun Xia, R. McEver, P. Koni, L. Silberstein, U. Andrian (2005)
Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells.Immunity, 22 2
(2006)
ONCOLOGY REPORTS
J. Trapani, V. Sutton (2003)
Granzyme B: pro-apoptotic, antiviral and antitumor functions.Current opinion in immunology, 15 5
A. Peterson, H. Harlin, T. Gajewski (2003)
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 12
J. Fonteneau, D. Kavanagh, M. Lirvall, C. Sanders, T. Cover, N. Bhardwaj, M. Larsson (2003)
Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.Blood, 102 13
C. Andreadis, K. Vahtsevanos, T. Sidiras, I. Thomaidis, K. Antoniadis, D. Mouratidou (2003)
5-Fluorouracil and cisplatin in the treatment of advanced oral cancer.Oral oncology, 39 4
O. Nakano, Makoto Sato, Y. Naito, Kensho Suzuki, S. Orikasa, M. Aizawa, Yasuyoshi Suzuki, Ichirou Shintaku, H. Nagura, H. Ohtani (2001)
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.Cancer research, 61 13
M. Harada, K. Tamada, K. Abe, Tieling Lı, Y. Onoe, H. Tada, M. Takenoyama, K. Yasumoto, G. Kimura, K. Nomoto (1998)
Systemic administration of interleukin‐12 can restore the anti‐tumor potential of B16 melanoma‐draining lymph node cells impaired at a late tumor‐bearing stateInternational Journal of Cancer, 75
Hiromichi Ando, M. Saio, N. Tamakawa, N. Ohe, T. Nakayama, Hai Yu, Y. Kaku, T. Iwama, J. Shinoda, N. Sakai, T. Takami (2002)
Failure of B7.1-modified tumor to evoke full activation of CD8+ tumor-infiltrating lymphocytes in the central nervous system: prevention of parental tumor growth in the subcutaneous environment.Journal of neurosurgery, 97 2
E. Unitt, S. Rushbrook, A. Marshall, S. Davies, P. Gibbs, L. Morris, N. Coleman, G. Alexander (2005)
Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T‐regulatory cellsHepatology, 41
E. Postema, P. Börjesson, W. Buijs, J. Roos, H. Marres, O. Boerman, R. Bree, M. Lang, G. Munzert, G. Dongen, W. Oyen (2003)
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 44 10
土井 理恵子 (2001)
Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma
D. Colnot, J. Roos, R. Bree, A. Wilhelm, J. Kummer, G. Hanft, K. Heider, G. Stehle, G. Snow, G. Dongen (2003)
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckCancer Immunology, Immunotherapy, 52
J. Tímár, A. Ladányi, C. Forster-Horváth, J. Lukits, B. Döme, É. Remenár, M. Gődény, M. Kásler, B. Bencsik, G. Répássy, G. Szabó, N. Velich, Z. Suba, János Élô, Z. Balatoni, K. Pócza, B. Zemplén, P. Chretien, E. Talor (2005)
Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 15
I. Ghobrial, T. Witzig (2004)
Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.Oncology, 18 5
M. Onaitis, M. Kalady, S. Pruitt, D. Tyler (2002)
Dendritic cell gene therapy.Surgical oncology clinics of North America, 11 3
S. Leong, M. Peng, Yuanda Zhou, J. Vaquerano, J. Chang (2002)
Cytokine profiles of sentinel lymph nodes draining the primary melanoma.Annals of surgical oncology, 9 1
P. Börjesson, E. Postema, R. Bree, J. Roos, C. Leemans, K. Kairemo, G. Dongen (2004)
Radioimmunodetection and radioimmunotherapy of head and neck cancer.Oral oncology, 40 8
B. Marsland, Patrick Bättig, M. Bauer, C. Ruedl, U. Lässing, R. Beerli, K. Dietmeier, Lidia Ivanova, T. Pfister, L. Vogt, H. Nakano, C. Nembrini, P. Saudan, M. Kopf, M. Bachmann (2005)
CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.Immunity, 22 4
S. Schoenberger, R. Toes, E. Voort, R. Offringa, C. Melief (1998)
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactionsNature, 393
H. Kokemueller, P. Brachvogel, A. Eckardt, J. Hausamen (2002)
Neck dissection in oral cancer--clinical review and analysis of prognostic factors.International journal of oral and maxillofacial surgery, 31 6
G. Key, M. Becker, B. Baron, M. Duchrow, C. Schlüter, H. Flad, Johannes Gerdes (1993)
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.Laboratory investigation; a journal of technical methods and pathology, 68 6
Hiromichi Ando, M. Saio, N. Ohe, N. Tamakawa, Hai Yu, T. Nakayama, S. Yoshimura, Y. Kaku, T. Iwama, J. Shinoda, N. Sakai, T. Takami (2002)
B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.International journal of oncology, 20 4
Lieping Chen, P. Linsley, K. Hellström (1993)
Costimulation of T cells for tumor immunity.Immunology today, 14 10
J. Stinchcombe, L. Page, Gillian Griffiths (2000)
Secretory Lysosome Biogenesis in Cytotoxic T Lymphocytes from Normal and Chediak Higashi Syndrome PatientsTraffic, 1
A. Coyle, J. Gutiérrez-Ramos (2001)
The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell functionNature Immunology, 2
J. Trapani, Joanne Davis, V. Sutton, Mark Smyth (2000)
Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.Current opinion in immunology, 12 3
J. Ridge, F. Rosa, P. Matzinger (1998)
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cellNature, 393
K. Sakakura, K. Chikamatsu, Tsutomu Sakurai, Katsumasa Takahashi, T. Murata, N. Oriuchi, N. Furuya (2005)
Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer.Oral oncology, 41 1
N. Lee, P. Xia, N. Fischbein, P. Akazawa, C. Akazawa, J. Quivey (2003)
Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.International journal of radiation oncology, biology, physics, 57 1
In order to evaluate host immune response to cancer, many methods have been applied. However, in the field of oral squamous cell carcinoma, evaluation of host immune response on the basis of proliferative activity of tumor-infiltrating T-cells (TIL) has not been reported. Therefore, we applied double immunohistochemical staining of proliferation markers Ki-67 and CD8 to surgically resected and paraffin-embedded tissue sections for 35 cases of oral squamous cell carcinoma. With this method, there was a significant correlation between the percentage of Ki-67+CD8+TIL and the intra-tumor epithelium infiltration rate of CD8+TIL (P=0.0237). In the process of analysis, we found that the proliferative activity of CD8+TIL tended to correlate (P=0.0859) with clinical N factor (lymph node metastasis), which was previously reported to suppress host immune response. We therefore assumed there was another factor inducing host immune response. The proliferative activity of CD8+TIL was well correlated with preoperative radiotherapy (P=0.0200) while there was no significant correlation between the proliferative activity of CD8+TIL and other clinical factors; age, tumor size, clinical stage, pathological N factor (P=0.5410, 0.7769, 0.1041, and 0.1072, respectively). Our present results strongly imply that preoperative radiotherapy is a very important factor in oral squamous cell carcinoma inducing host immune response regardless of the clinical factors present.
Oncology Reports – Spandidos Publications
Published: Apr 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.